Trinity Biotech(TRIB) - 2024 Q1 - Quarterly Report

Exhibit 99.1 Contact: Trinity Biotech plc LifeSci Partners, LLC Des Fitzgerald Eric Ribner (353)-1-276980 0 (1)-646-751-4363 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates DUBLIN, Ireland (April 4, 2024)…. Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarte ...